{"name":"Amplia Therapeutics Limited","slug":"amplia-therapeutics-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"AMP945 RP2D","genericName":"AMP945 RP2D","slug":"amp945-rp2d","indication":"Other","status":"phase_1"},{"name":"AMP945 ascending doses","genericName":"AMP945 ascending doses","slug":"amp945-ascending-doses","indication":"Other","status":"phase_1"},{"name":"narmafotinib dose comparison","genericName":"narmafotinib dose comparison","slug":"narmafotinib-dose-comparison","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AMP945 RP2D","genericName":"AMP945 RP2D","slug":"amp945-rp2d","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AMP945 ascending doses","genericName":"AMP945 ascending doses","slug":"amp945-ascending-doses","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"narmafotinib dose comparison","genericName":"narmafotinib dose comparison","slug":"narmafotinib-dose-comparison","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQWHlWY2tpV1dtNDRxNmh2NnFoVkxELUZNc3JEQkNqNUFTSkxZZ1ZxTlB0TmtUY2NkMHdaY1FVb0VoWlY4Z05sQ3NSaVBXTHFNSzhxZGczLUdDTG9MTWY5WG5Wc0ZxaGsyTEZ2MFZxUEUwRDM4SDB5ZllVSkhSSFlVRmtuV1JucE5wNFpQMDdnTFIyNW5xUGxaUFFKbHJPT2k1dkE?oc=5","date":"2026-04-07","type":"trial","source":"BioWorld News","summary":"Amplia halts enrollment in phase II pancreatic cancer trial - BioWorld News","headline":"Amplia halts enrollment in phase II pancreatic cancer trial","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE1KdlNqMmdUOXkyTWpBdVNCVl96YXlQTzY5VmFlSTVreFVtVXdkbFhZWl9pb1JIOERrb3MzQmgtcWN6M0JkNnVCTHh1cWxRTm9KdGhGWElwQTJNSTQxTXkycVJjUXNVY1VCTHhF?oc=5","date":"2026-04-03","type":"pipeline","source":"Yahoo! Finance Canada","summary":"ImmuPharma PLC (25I.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada","headline":"ImmuPharma PLC (25I.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxOSnlwQ2pXeml5SkFnSEVIN0xPRURlbVA5NFZhektTbEJjcHdiM05GZFpfZnRqQ3JsaGVySkpubUhvbTBaWHowME5uMDctaGZNUnVxYm1KUHQybTBLSEMzYjVZY3Q4N09HLUZSbUEtNUlDYTZOdE1JbW1ZSXEtNkxhb2otZ3F4S2ktaE5YM1NEaWFYcjVXUzlickFVd1BUTWdpdFVRb0w0VkFtNGNmSHBPb1NLLWZUNUMwS2Q0SjJoNmJ6dnBpdWZUQnhkUzE1cm56RWU1OTFqOGhYX0lDTVAyR1VfaXpzUDR4RGJ5Uk4yVS0waWdkLWdiRVJXSW5pY2xNcEN6alZfaDRXeTJkYTJ0U204ZXhyUV9vV2hNQjRPNlMzWGV1RUJCSUxfVmI5UXA2cFIxVThQdTB5Wm9aUmdkbVJhZU9RWEF4WE1BT19sOEhHZw?oc=5","date":"2026-03-23","type":"trial","source":"The Malone Telegram","summary":"Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic Cancer Trial - The Malone Telegram","headline":"Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxPdlRWT2IzNDJ3cXd4Tm40N2VCc0VvbS00VkE0V0U5dWpveWtJRHZ3N3NEVm42eHRxeldTYThOMWc0R2J4U3VmQy1uWXpDRGFTSDZlU0N1U3dQNHN3S0RLTkdHN09wMi1Mel9CTm95NjZZZUFYM1Q4M2J0OENBOWZmMHhENUJjc2xlV0NIUWxuWjV0d1lMWDlkQjVIQ2ZXbkxpQWJrSDVNWWw3OG5SSVVhLXZFclJRQWExN1ZVNGpCamtMYURmcmR2b0JobkhONERNbVMyYlBLM0UxQlpiU2tnNjFtejJPZms?oc=5","date":"2026-03-11","type":"pipeline","source":"GlobeNewswire","summary":"Amplia Therapeutics to Present at the Life Sciences Investor Forum on March 12th - GlobeNewswire","headline":"Amplia Therapeutics to Present at the Life Sciences Investor Forum on March 12th","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxPUVkydWk3TFlLMy1HUUxHSUdzOGRGeWFiZFptY0N1M1hScklxUFBpR1RyUm4yVHkzR0k3Ym1tempDY0Nmak00VFZiOVN3S0tOa2xFQXp5MDZlMnFQSmNjaWlvZVNkU3NlamNIUDlWSWJ2dk5zZWp6emxiR0JuVnQwRXhGaE55V2ZTSXFZS3JsQ21iYmpMMjNxQzAxdXpkdFJ3bm1zZEN2TUVBRk44V1Y2Ym9GY1h6ZXJxWWdfZEd3QVZjZ29MelplT2Y4RUlER2JIaUxrWVkwSkxlZUp6YnY5b0d6OVZ5VDd6WVdWZU5reEF3dzV1bjZNbGNIdm15MXB1?oc=5","date":"2026-03-10","type":"pipeline","source":"The Globe and Mail","summary":"B2i Digital Highlights Life Sciences Virtual Investor Forum as a Featured Conference - The Globe and Mail","headline":"B2i Digital Highlights Life Sciences Virtual Investor Forum as a Featured Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNMVB4WHFxOEdBUmtrV3dhcUEtejMxbDRuX0VWWmY1WEdsRUhZLTB3Zk9WTVdudkVIV1UxelNZa3pzRU5hVTczQnVSZWFSc0x5TklzeW1oUERxMXZfRTJZZFdmaXdoYWY1aWIxWXJTczZnU3AyajhXWFdaSVFHM0RiTGR2NkoyTXllU29YYnZpcFVpWFFqQldROHE4T0xSNmtQZllwWXBkV19GSFJYLVQ3VzV2T1ktUjkxY01ldVlhS1pMT2dJbmlPR2JB?oc=5","date":"2026-03-04","type":"earnings","source":"Stockhead","summary":"February Health Winners: Tough earnings season saw sector sink 13pc, but which standouts rose? - Stockhead","headline":"February Health Winners: Tough earnings season saw sector sink 13pc, but which standouts rose?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxONk9ITDVHV244OHgwamMwVWhlZ0xQTWJsb0NZZmFhUmZwNG9kWWdrd3N5WjZxTUJxQmVTaHFPSGwzM2RMWDlYMWhEcXY0NXlBUWl5N3lPV2Vhd240aVBkamlmMGxsVDBWblhITzR1eFF6VVRMU1pmS0psQlNMaWtHeW1xWDI1bUJLLXM2WlM0eHJkMEFuckNRY1hMcVlvN0lJUHN0SWpSS21wXzZLa044OU82cDVxX0FRcVhB?oc=5","date":"2026-02-18","type":"pipeline","source":"proactiveinvestors.com","summary":"ASX sets date for March 2026 SMIDcaps Conference - proactiveinvestors.com","headline":"ASX sets date for March 2026 SMIDcaps Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxNNURrb1dSUXNiU0YtYnJLSjExMnhpckNGcE13TnEyd0pFUDFtSy1OQmpPNDdpWjVsM0FUem9PcXJJZFZOaVhKdlVXdnRFZDc0Rm45NFlTbnI0M0xXZTNuSE82MUh4d3lvM3padHd5MDJyMnNvNnBQbWNZSFlHckc4dDJkaEdVOUNETXhBRHNBSjNUUXRxeU8tYnNYQWdiYXV1NUJIZ0l2bEU5SGlTbGZTdTNsQkRTUGxkZmZqbTdBam5EWUx0RHlKR1lJMzN1S1REajZ4elBLUFQ5OUotOHVYR1I4TjNqRDQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Proactive financial news","summary":"Second agreement builds on Amplia Therapeutics' early pancreatic cancer results | ASX:ATX, OTCQB:INNMF - Proactive financial news","headline":"Second agreement builds on Amplia Therapeutics' early pancreatic cancer results | ASX:ATX, OTCQB:INNMF","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPSFEzcGU4WEdNR2tvSzllbzUzazJFWkRZVXB2Q0NYRk1mSkdrVnVhdEx5M3pEcVNFV19RTlZ1YV8wZ0p3VkQwX2xJNG4zd2JLNlY3WTg0NUVObjI1Y3NwR1hwWUF1cWZDanVnLV9CQmlKb0FVaDhpekpLclJQQjRSbWljclh4azlPanFRTDcwUmZQOENwUHV5a25UZ1NxMGpzWU9pcnR0dkt4NVp2eW0zUg?oc=5","date":"2025-07-23","type":"pipeline","source":"Sharecafe","summary":"Amplia Therapeutics Announces $25 Million Placement and $2.5 Million SPP - Sharecafe","headline":"Amplia Therapeutics Announces $25 Million Placement and $2.5 Million SPP","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-04-09","type":"pipeline","source":"simplywall.st","summary":"Insider Purchases Worth AU$949.9k See Losses As Amplia Therapeutics Market Value Drops To AU$21m - simplywall.st","headline":"Insider Purchases Worth AU$949.9k See Losses As Amplia Therapeutics Market Value Drops To AU$21m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBnQk16ZG1KV2dsOGRPZUpmajRpellQNDcwWXMwQW5TaGVQbVR3VnM0UC0xazVULVIyb0M1WFJWcWViLTYwbE1rWVVZdmVEQzJUdnplRnRhYlV0U2pteF8xUWlHZkFlWXM2UDVvdmln0gFyQVVfeXFMUFl2UHpZSTdhY19tQjlFMFBOcmtYZUdtTGxVNlg4UXNHY0pyZ2lmWE0ySjhaNnpfd3FZeUJGTUtoY0Q2X244R0NPalFVSnphRmFYOGVtNFpGSHp3a2tNaTBQZUpBUjU1c1JSUVFONVBDdUJn?oc=5","date":"2024-11-13","type":"pipeline","source":"koreabiomed.com","summary":"NEXT & BIO to work with Amplia to develop pancreatic cancer drug - koreabiomed.com","headline":"NEXT & BIO to work with Amplia to develop pancreatic cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOTXhkS2hWZW1fRkh4dXRPZXBvMS0wUk1LRVBhbXB3NGwzZlFER1FXc2lWYjhBT1d2cV82Ql9aVGpja1ZuaXJTMlM4MDZ0RjZ1WjFMZHFmNFBxaU4wMFlvcVVCOEVEaWFSMUNKYmx3STROVVB1Z2s4QUstam9LRGpFYXJZVWNOcGdyQWdzNU9YbFIyRmE3cGkxZWg5djVfWmJtd2lkbnpRUGZKS1Fid1dwVHN6dGNkZ1NSUU9uQXNwbXlLT0htQmxjMA?oc=5","date":"2024-09-19","type":"regulatory","source":"prnewswire.com","summary":"FDA FAST TRACK DESIGNATION FOR NARMAFOTINIB IN ADVANCED PANCREATIC CANCER - prnewswire.com","headline":"FDA FAST TRACK DESIGNATION FOR NARMAFOTINIB IN ADVANCED PANCREATIC CANCER","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_1":3},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}